Get started
Author

Anne Casson

Observed names: A Casson, A. Casson
OpenAlex ID: A5048845499
Respiratory syncytial virus infection following hematopoietic stem cell transplantation
2002 · TN Small, A Casson, et al. · Bone Marrow Transplantation · 109
Safety and Immunogenicity of the Live Attenuated Varicella Vaccine Following T Replete or T Cell-Depleted Related and Unrelated Allogeneic Hematopoietic Cell Transplantation (alloHCT)
2011 · Joanne F. Chou, Nancy A. Kernan, et al. · Transplantation and Cellular Therapy · 57
PDF
A Coordinated Clinical Center for Young Onset Colorectal Cancer
2021 · Robin Mendelsohn, Randze Lerie Palmaira, et al. · The Oncologist · 16
PDF
Fertility outcomes post immune checkpoint inhibitor exposure
2024 · Emily C. Harrold, Martinique Ogle, et al. · Cancer Cell · 7
Vaccine Reponses Following Unmodified or T Cell Depleted Unrelated and Mismatched Related HCT.
2004 · Trudy N. Small, Esperanza B. Papadopoulos, et al. · Blood · 4
Immunogenicity of the Tetravalent Protein-Conjugated Meningococcal Vaccine in Recipients of Related and Unrelated Allogeneic Hematopoietic Cell Transplants (HCT)
2008 · Michelle Mahler, Nancy A Kernan, et al. · Blood · 3
Immunogenicity of the Live Attenuated Varicella Vaccine Following Allogeneneic HCT.
2009 · Trudy N Small, Nancy A. Kernan, et al. · Blood · 2
Fludarabine (Flu) Based Cytoreductive Regimen and T-Cell Depleted Grafts from Unrelated or Mismatched Related Donors for the Treatment of High Risk Patients with Fanconi Anemia (FA).
2004 · Farid Boulad, Arleen D. Auerbach, et al. · Blood · 2
T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (<21 years) with AML in CR1
2016 · Nancy A. Kernan, Farid Boulad, et al. · Transplantation and Cellular Therapy
T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (<21 years) with AML in CR1 or CR2 or MDS Including tMDS/AML
2015 · Nancy A. Kernan, Farid Boulad, et al. · Blood
Hematopoietic stem cell transplantation for the treatment of fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell depleted grafts from alternative donors
2004 · F. Boulad, A.D. Auerbach, et al. · Transplantation and Cellular Therapy
Works count: 11
Citation count: 200
H-index: 4
I10-index: 3
Year
Topic
Type